We describe two patients who suffered transient neonatal diabetes mellitus (TDNM), due to paternal isodisomy of chromosome 6. One patient, now 5 years old, had severe intra-uterine growth retardation, but recovered normal growth parameters. The other patient, currently 12 years old, had a normal birth weight but showed impaired post-natal growth; in addition to TNDM the patient presented with cardiac and thyroid abnormalities. These cases may suggest that the clinical phenotype of TNDM is more variable than previously believed. The contribution of genetic and epigenetic factors needs to be determined to elucidate the phenotype-genotype relationships of this disease.
Introduction
Neonatal diabetes mellitus (NDM) is a very rare entity with an estimated incidence of 1/400 000-1/500 000 births in Europe. 1 Neonates with NDM have an absolute requirement for insulin to maintain blood glucose. In about half of the NDM cases, the diabetes is transient (TNDM, MIM 601410). TNDM is frequently associated with intra-uterine growth retardation (IUGR) and very low adiposity. TNDM usually resolves before 6 months, but type-2 diabetes mellitus has been reported later in life. Chromosome 6 duplications, 2, 3 and paternal uniparental disomy of chromosome 6 (UPD6), isodisomy, have been described in patients with TNDM. 4, 5 A candidate region on 6q23-q24 has been identified with an imprinted gene thought to be involved in the maturation of pancreatic beta-cells. 6 We report two further cases of TNDM with paternal UPD6, with different growth patterns and clinical abnormalities.
Patients and methods

Clinical report
Two children were diagnosed with idiopathic TNDM. Table 1 shows the main clinical features and laboratory findings.
Child A is the first child of unrelated parents of Moroccan origin, the younger sister is unaffected. The plasma glucose concentration was 5 mmol/l, 5 hours after birth. Plasma insulin concentration was < 3 mU/l and plasma C peptide concentration 0.16 pmol/l. Insulin was given intravenously at 0.15 mU/kg/day. After cessation of insulin, capillary blood glucose varied between 7 and 12 mmol/l. Follow-up included glycated haemoglobin assays; oral glucose tolerance test and titrations of islet-cell antibodies (ICA, IAA, IA2, GAD) at 1, 2, and 4 years of age were in the normal range. Height and weight reached the main reference values curves by 1 year of age and have remained around this level since. Child B is the fourth child of consanguineous parents of Moroccan origin. Three older siblings were unaffected. The newborn presented with vital distress requiring external cardiac stimulation. On the first day of life the child presented with hypotonia and seizures which were controlled with phenitoine. TNDM in patient B was associated with other severe pathological features (Table 1) . Statural growth is abnormal, height being 134 cm (-2σ) and weight 25 kg (-2.5σ) at age 10 years.
Genotyping 10-20 ml of peripheral blood were drawn from each patient and parents after they gave their informed consent. Genomic DNA was extracted from blood with the Nucleon BACC2 kit 
Results
The results of genotyping with 21 microsatellite markers distributed along the whole of chromosome 6 are given in Figure 1 . The marker alleles were apparently homozygous all along chromosome 6 in both patients. The inherited alleles were of paternal origin with no maternal contributionevidence of a paternal UPD6. The paternal isodisomy is demonstrable at 10 loci for child A and 14 loci for child B (Figure 1 ). Markers which were not fully informative were inherited in a pattern consistent with homozygosity for the paternal allele. Markers from other chromosomes including 20 markers on chromosome 11 (not shown), were inherited in a Mendelian mode. Routine karyotypes were normal.
Discussion
We report two new TNDM cases with paternal isodisomy of chromosome 6. UPD6 has previously been reported to be associated with various clinical features such as complement deficiency, 8 NDM with methyl malonic acidaemia and pancreatic cells agenesis, 9 and TNDM with macroglossia. 10 The association between TNDM and paternal UPD6 has been observed in at least six independent cases in various ethnic groups. 4, 5 These recent reports and our observation are in favour of the involvement of imprinted gene(s) on the chromosome region 6q23-q24. 6 Chromosome 6 paternal isodisomy is found in approximately 20-30% of patients with TNDM. It is thus a common genetic mechanism of the disease, but different from that involved in the BeckwithWiedemann and Prader-Willi/Angelman syndromes in which the UPD described are segmentary and located at the 11p15.5 and 15q11-q13 imprinted domains, respectively. Paternal duplications of the 6q23-qter chromosomal region found in some patients with TNDM, 2, 3 suggest that a gain of function of a paternally expressed gene may be involved. Maternal UPD6 has been reported in two cases with no evidence of TNDM: 11 once in a genome-screen linkage study, and once in HLA typing. 11, 12 The apparently low incidence of TNDM in the European population could be due to patients not requiring insulin therapy at birth going undiagnosed. Paternal isodisomy of chromosome 6 in TNDM y IUGR and low birth weight in TNDM could result from the lack of insulin as a growth factor in utero. It would be valuable to identify genes participating in birth weight control, since low birth weight is a condition that reduces perinatal survival and increases the risk of cardiovascular disease, and type 2 diabetes in adult life. 14 TNDM in patient A is typical of 'classic TNDM, 15 after 5 years she is healthy. Patient B had impaired statural and ponderal post-natal growth and other pathological features (cardiac anomalies and hypothyroidism) in addition to TNDM. Although hypothyroidism may be due to complications of major thalassaemia, 16 there are alternative possible explanations: unmasking of an autosomal recessive mutation due to the chromosome 6 isodisomy, or consanguinity of the parents resulting in a recessive disorder. Other mechanisms such as i) a multiendocrine alteration process, ii) imbalance in signalling, iii) imprinting effects (target tissue, variable tissue responses to stimuli, the mutation type, and the parental origin of the allele which bears the mutation), are also possible. Further investigations are needed to identify the clinical spectrum of TNDM, its genetic and molecular basis, and to evaluate its impact on more common forms of diabetes such as non insulin-dependent diabetes mellitus (NIDDM). 
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